ResearcherGuiyang Medical UniversityNo recent work listed

Jian Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4257-331X; OpenAlex author ID A5027702007. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway. Co-author DOI 10.1155/2023/1728463 ↗
Advances in the Surgical Treatment of Pancreatic Cancer. Co-author DOI 10.1016/j.path.2022.05.003 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Amer H. Zureikat · 1 shared paper, 2022 · strength 0.26
- Paper Advances in the Surgical Treatment of Pancreatic Cancer. DOI 10.1016/j.path.2022.05.003 ↗
Alessandro Paniccia · 1 shared paper, 2022 · strength 0.26
- Paper Advances in the Surgical Treatment of Pancreatic Cancer. DOI 10.1016/j.path.2022.05.003 ↗
Chao Yu · 1 shared paper, 2023 · strength 0.22
- Paper RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway. DOI 10.1155/2023/1728463 ↗
Hao Hua · 1 shared paper, 2023 · strength 0.22
- Paper RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway. DOI 10.1155/2023/1728463 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.